The increasing liberalisation of cannabis across the world is fuelling excitement among investors who regard the drug as the next big trend for both consumers and medicine.
In October, Canada became the second country, after Uruguay, to legalise the possession and recreational consumption of marijuana.
Canadian cannabis companies such as Canopy Growth, Tilray, Aurora and Cronos were not well known to investors at the beginning of the year, but by October their stocks were “flying high”, says financial news site InvestorPlace.
So will the green rush be the next gold rush?
Sativa Investments PLC invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical cannabis. Their investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.